Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Influenza

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 369 articles:
HTML format



Single Articles


    October 2020
  1. GAO Q, Yang C, Ren C, Zhang S, et al
    Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
    J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
    PubMed     Abstract available


  2. MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
    A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
    J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
    PubMed     Abstract available


  3. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    PubMed     Abstract available


  4. ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
    PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
    J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
    PubMed     Abstract available


  5. WEI Y, Zeng Y, Zhang X, Xu S, et al
    The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
    J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
    PubMed     Abstract available


    September 2020
  6. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    PubMed     Abstract available


  7. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    PubMed     Abstract available


  8. MELIOPOULOS V, Cherry S, Wohlgemuth N, Honce R, et al
    Primary swine respiratory epithelial cell lines for the efficient isolation and propagation of influenza A viruses.
    J Virol. 2020 Sep 23. pii: JVI.01091-20. doi: 10.1128/JVI.01091.
    PubMed     Abstract available


  9. ZHANG X, Cunningham FL, Li L, Hanson-Dorr K, et al
    Tissue tropisms of avian influenza A viruses affect their spillovers from wild birds to pigs.
    J Virol. 2020 Sep 23. pii: JVI.00847-20. doi: 10.1128/JVI.00847.
    PubMed     Abstract available


  10. STEINER F, Pavlovic J
    Subcellular localization of MxB determines its antiviral potential against influenza A virus.
    J Virol. 2020 Sep 9. pii: JVI.00125-20. doi: 10.1128/JVI.00125.
    PubMed     Abstract available


  11. SONG J, Sun H, Sun H, Jiang Z, et al
    Swine microRNAs ssc-miR-221-3p and ssc-miR-222 restrict the cross-species infection of avian influenza virus.
    J Virol. 2020 Sep 9. pii: JVI.01700-20. doi: 10.1128/JVI.01700.
    PubMed     Abstract available


  12. EL-SHESHENY R, Franks J, Turner J, Seiler P, et al
    Continued Evolution of H5Nx Avian Influenza Viruses in Bangladeshi Live Poultry Markets: Pathogenic Potential in Poultry and Mammalian Models.
    J Virol. 2020 Sep 9. pii: JVI.01141-20. doi: 10.1128/JVI.01141.
    PubMed     Abstract available


  13. KIRKPATRICK E, Henry C, McMahon M, Jiang K, et al
    Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity.
    J Virol. 2020 Sep 9. pii: JVI.01185-20. doi: 10.1128/JVI.01185.
    PubMed     Abstract available


  14. CHIA BS, Li B, Cui A, Eisenhaure T, et al
    Loss of the nuclear protein RTF2 enhances influenza replication.
    J Virol. 2020 Sep 2. pii: JVI.00319-20. doi: 10.1128/JVI.00319.
    PubMed     Abstract available


    August 2020
  15. GAO R, Sreenivasan CC, Sheng Z, Hause BM, et al
    Human Monoclonal Antibody Derived from Transchromosomic (Tc) Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the HA Head Domain.
    J Virol. 2020 Aug 26. pii: JVI.00945-20. doi: 10.1128/JVI.00945.
    PubMed     Abstract available


  16. VIGIL A, Frias-Staheli N, Carabeo T, Wittekind M, et al
    Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Anti-Viral Activities and Enables Broad Coverage Combination Therapies.
    J Virol. 2020 Aug 26. pii: JVI.00052-20. doi: 10.1128/JVI.00052.
    PubMed     Abstract available


  17. DANIELS RS, Tse H, Ermetal B, Xiang Z, et al
    Molecular characterisation of Influenza C viruses from outbreaks in Hong Kong SAR, China.
    J Virol. 2020 Aug 19. pii: JVI.01051-20. doi: 10.1128/JVI.01051.
    PubMed     Abstract available


  18. WANG Y, Lv Y, Niu X, Dong J, et al
    L226Q mutation on influenza H7N9 virus hemagglutinin increases receptor-binding avidity and leads to biased antigenicity evaluation.
    J Virol. 2020 Aug 12. pii: JVI.00667-20. doi: 10.1128/JVI.00667.
    PubMed     Abstract available


    July 2020
  19. CLEMENTS AL, Sealy JE, Peacock TP, Sadeyen JR, et al
    Contribution of segment 3 to the acquisition of virulence in contemporary H9N2 avian influenza viruses.
    J Virol. 2020 Jul 29. pii: JVI.01173-20. doi: 10.1128/JVI.01173.
    PubMed     Abstract available


  20. OSTBYE H, Gao J, Rakic Martinez M, Wang H, et al
    N-linked glycan sites on the influenza NA head domain are required for efficient IAV incorporation and replication.
    J Virol. 2020 Jul 22. pii: JVI.00874-20. doi: 10.1128/JVI.00874.
    PubMed     Abstract available


  21. CHANG P, Sealy JE, Sadeyen JR, Bhat S, et al
    Immune escape adaptive mutations in the H7N9 avian influenza hemagglutinin protein increase virus replication fitness and decrease pandemic potential.
    J Virol. 2020 Jul 22. pii: JVI.00216-20. doi: 10.1128/JVI.00216.
    PubMed     Abstract available


  22. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    PubMed     Abstract available


  23. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    PubMed     Abstract available


  24. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    PubMed     Abstract available


  25. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    PubMed     Abstract available


  26. ARAI Y, Elgendy EM, Daidoji T, Ibrahim MS, et al
    H9N2 influenza virus infections in human cells require a balance between NA sialidase activity and HA receptor affinity.
    J Virol. 2020 Jul 8. pii: JVI.01210-20. doi: 10.1128/JVI.01210.
    PubMed     Abstract available


  27. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    PubMed     Abstract available


  28. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    PubMed     Abstract available


  29. BELSER JA, Sun X, Brock N, Pappas C, et al
    Genetically and antigenically divergent influenza A(H9N2) viruses exhibit differential replication and transmission phenotypes in mammalian models.
    J Virol. 2020 Jul 1. pii: JVI.00451-20. doi: 10.1128/JVI.00451.
    PubMed     Abstract available


  30. WAN XF, Ferguson L, Oliva J, Rubrum A, et al
    Limited cross-protection provided by prior infection contributes to high prevalence of influenza D viruses in cattle.
    J Virol. 2020 Jul 1. pii: JVI.00240-20. doi: 10.1128/JVI.00240.
    PubMed     Abstract available


    June 2020
  31. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    PubMed     Abstract available


  32. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    PubMed     Abstract available


  33. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    PubMed     Abstract available


  34. XU C, Xu B, Wu Y, Yang S, et al
    Erratum for Xu et al., "A Single Amino Acid at Position 431 of the PB2 Protein Determines the Virulence of H1N1 Swine Influenza Viruses in Mice".
    J Virol. 2020;94.
    PubMed    


  35. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    PubMed    


  36. ZHENG A, Sun W, Xiong X, Freyn AW, et al
    Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    J Virol. 2020 Jun 3. pii: JVI.00742-20. doi: 10.1128/JVI.00742.
    PubMed     Abstract available


    May 2020
  37. LIU L, Song S, Shen Y, Ma C, et al
    Truncation of PA-X contributes to virulence and transmission of H3N8 and H3N2 canine influenza viruses in dogs.
    J Virol. 2020 May 27. pii: JVI.00949-20. doi: 10.1128/JVI.00949.
    PubMed     Abstract available


  38. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    PubMed     Abstract available


  39. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    PubMed     Abstract available


  40. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    PubMed     Abstract available


  41. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    PubMed     Abstract available


    April 2020
  42. MINE J, Uchida Y, Takemae N, Saito T, et al
    Genetic characterization of influenza A viruses in Japanese swine during 2015-2019.
    J Virol. 2020 Apr 29. pii: JVI.02169-19. doi: 10.1128/JVI.02169.
    PubMed     Abstract available


  43. EGGINK D, Spronken M, van der Woude R, Buzink J, et al
    Phenotypic effects of substitutions within the receptor binding site of highly pathogenic avian influenza H5N1 observed during human infection.
    J Virol. 2020 Apr 22. pii: JVI.00195-20. doi: 10.1128/JVI.00195.
    PubMed     Abstract available


  44. VERHAGEN JH, Poen M, Stallknecht DE, van der Vliet S, et al
    Phylogeography and antigenic diversity of low pathogenic avian influenza H13 and H16 viruses.
    J Virol. 2020 Apr 22. pii: JVI.00537-20. doi: 10.1128/JVI.00537.
    PubMed     Abstract available


  45. RAHIM MMA, Parsons BD, Price EL, Slaine PD, et al
    Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins.
    J Virol. 2020 Apr 22. pii: JVI.00165-20. doi: 10.1128/JVI.00165.
    PubMed     Abstract available


  46. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    PubMed     Abstract available


  47. KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
    Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    J Virol. 2020;94.
    PubMed     Abstract available


  48. WIGNALL-FLEMING EB, Vasou A, Young D, Short JAL, et al
    Innate intracellular antiviral responses restrict the amplification of defective virus genomes of Parainfluenza Virus type 5.
    J Virol. 2020 Apr 15. pii: JVI.00246-20. doi: 10.1128/JVI.00246.
    PubMed     Abstract available


  49. WALKER AP, Sharps J, Fodor E
    Mutation of an influenza virus polymerase 3' RNA promoter binding site inhibits transcription elongation.
    J Virol. 2020 Apr 15. pii: JVI.00498-20. doi: 10.1128/JVI.00498.
    PubMed     Abstract available


  50. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    PubMed     Abstract available


  51. PEACOCK TP, Swann OC, Salvesen HA, Staller E, et al
    Swine ANP32A supports avian influenza virus polymerase.
    J Virol. 2020 Apr 8. pii: JVI.00132-20. doi: 10.1128/JVI.00132.
    PubMed     Abstract available


  52. OKUYA K, Yoshida R, Manzoor R, Saito S, et al
    A potential role of non-neutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes.
    J Virol. 2020 Apr 8. pii: JVI.00408-20. doi: 10.1128/JVI.00408.
    PubMed     Abstract available


  53. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    PubMed     Abstract available


  54. VIGEVENO RM, Poen MJ, Parker E, Holwerda M, et al
    Outbreak severity of highly pathogenic avian influenza A(H5N8) viruses is inversely correlated to polymerase complex activity and interferon induction.
    J Virol. 2020 Apr 1. pii: JVI.00375-20. doi: 10.1128/JVI.00375.
    PubMed     Abstract available


  55. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    PubMed     Abstract available


  56. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    PubMed     Abstract available


    March 2020
  57. DISKIN ER, Friedman K, Krauss S, Nolting JM, et al
    Subtype diversity of influenza A virus in North American waterfowl: a multi-decade study.
    J Virol. 2020 Mar 18. pii: JVI.02022-19. doi: 10.1128/JVI.02022.
    PubMed     Abstract available


  58. CLOHISEY S, Parkinson N, Wang B, Bertin N, et al
    Comprehensive characterisation of transcriptional activity during influenza A virus infection reveals biases in cap-snatching of host RNA sequences.
    J Virol. 2020 Mar 11. pii: JVI.01720-19. doi: 10.1128/JVI.01720.
    PubMed     Abstract available


  59. SUN Y, Hu Z, Zhang X, Chen M, et al
    R195K mutation in the PA-X protein increases the virulence and transmission of influenza A virus in mammalian hosts.
    J Virol. 2020 Mar 11. pii: JVI.01817-19. doi: 10.1128/JVI.01817.
    PubMed     Abstract available


    February 2020
  60. WANG B, Saito Y, Nishimura M, Ren Z, et al
    An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.
    J Virol. 2020;94.
    PubMed     Abstract available


  61. FIGUEROA T, Bessiere P, Coggon A, Bouwman KM, et al
    THE MICROBIOTA CONTRIBUTES TO THE CONTROL OF HIGHLY PATHOGENIC H5N9 INFLUENZA VIRUS REPLICATION IN DUCKS.
    J Virol. 2020 Feb 26. pii: JVI.00289-20. doi: 10.1128/JVI.00289.
    PubMed     Abstract available


  62. ISHIDA H, Murakami S, Kamiki H, Matsugo H, et al
    Establishment of a Reverse Genetics System for Influenza D Virus.
    J Virol. 2020 Feb 26. pii: JVI.01767-19. doi: 10.1128/JVI.01767.
    PubMed     Abstract available


  63. FORBESTER JL, Clement M, Wellington D, Yeung A, et al
    IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived myeloid cells and murine models.
    J Virol. 2020 Feb 19. pii: JVI.00121-20. doi: 10.1128/JVI.00121.
    PubMed     Abstract available


  64. CASTRO IA, Jorge DMM, Ferreri LM, Martins RB, et al
    Silent infection of B and CD8(+)T lymphocytes by influenza A virus in children with tonsillar hypertrophy.
    J Virol. 2020 Feb 19. pii: JVI.01969-19. doi: 10.1128/JVI.01969.
    PubMed     Abstract available


  65. BARNARD KN, Alford-Lawrence BK, Buchholz DW, Wasik BR, et al
    Modified sialic acids on mucus and erythrocytes inhibit influenza A HA and NA functions.
    J Virol. 2020 Feb 12. pii: JVI.01567-19. doi: 10.1128/JVI.01567.
    PubMed     Abstract available


  66. BALACHANDRAN S, Rall GF
    The Benefits and Perils of Necroptosis in Influenza Infection.
    J Virol. 2020 Feb 12. pii: JVI.01101-19. doi: 10.1128/JVI.01101.
    PubMed     Abstract available


    January 2020
  67. XU C, Xu B, Wu Y, Yang S, et al
    A single amino acid at position 431 of the PB2 protein determines the virulence of H1N1 swine influenza viruses in mice.
    J Virol. 2020 Jan 29. pii: JVI.01930-19. doi: 10.1128/JVI.01930.
    PubMed     Abstract available


  68. SKARLUPKA AL, Reneer ZB, Abreu RB, Ross TM, et al
    An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses.
    J Virol. 2020 Jan 29. pii: JVI.02061-19. doi: 10.1128/JVI.02061.
    PubMed     Abstract available


  69. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    PubMed     Abstract available


  70. BEERENS N, Heutink R, Harders F, Bossers A, et al
    Emergence and selection of a highly pathogenic avian influenza H7N3 virus.
    J Virol. 2020 Jan 22. pii: JVI.01818-19. doi: 10.1128/JVI.01818.
    PubMed     Abstract available


  71. WONG SS, Waite B, Ralston J, Wood T, et al
    Hemagglutinin and neuraminidase antibodies are induced in an age- and subtype- dependent manner after influenza virus infection.
    J Virol. 2020 Jan 15. pii: JVI.01385-19. doi: 10.1128/JVI.01385.
    PubMed     Abstract available


  72. PARK JG, Avila-Perez G, Nogales A, Blanco-Lobo P, et al
    Identification and characterization of novel compounds with broad spectrum antiviral activity against influenza A and B viruses.
    J Virol. 2020 Jan 15. pii: JVI.02149-19. doi: 10.1128/JVI.02149.
    PubMed     Abstract available


  73. XIA C, Wolf JJ, Sun C, Xu M, et al
    PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor.
    J Virol. 2020 Jan 8. pii: JVI.01572-19. doi: 10.1128/JVI.01572.
    PubMed     Abstract available


  74. LE NOUEN C, Luongo CL, Yang L, Mueller S, et al
    Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity.
    J Virol. 2020;94.
    PubMed     Abstract available


  75. AGGARWAL M, Leser GP, Lamb RA
    Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses.
    J Virol. 2020 Jan 2. pii: JVI.01888-19. doi: 10.1128/JVI.01888.
    PubMed     Abstract available


    December 2019
  76. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
    J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
    PubMed     Abstract available


  77. QIU Y, Stegalkina S, Zhang J, Boudanova E, et al
    Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    J Virol. 2019 Dec 11. pii: JVI.01035-19. doi: 10.1128/JVI.01035.
    PubMed     Abstract available


  78. PARSONS L, An Y, Qi L, White M, et al
    Influenza Hemagglutinins H2, H5, H6, and H11 are not Targets of Pulmonary Surfactant Protein D: N-glycan subtypes in host-pathogen interactions.
    J Virol. 2019 Dec 11. pii: JVI.01951-19. doi: 10.1128/JVI.01951.
    PubMed     Abstract available


  79. VALESANO AL, Fitzsimmons WJ, McCrone JT, Petrie JG, et al
    Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts.
    J Virol. 2019 Dec 4. pii: JVI.01710-19. doi: 10.1128/JVI.01710.
    PubMed     Abstract available


  80. ZHONG G, Fan S, Hatta M, Nakatsu S, et al
    Mutations in the NA-like protein of bat influenza H18N11 virus enhance virus replication in mammalian cells, mice, and ferrets.
    J Virol. 2019 Dec 4. pii: JVI.01416-19. doi: 10.1128/JVI.01416.
    PubMed     Abstract available


    November 2019
  81. OLIVA J, Mettier J, Sedano L, Delverdier M, et al
    A murine model for the study of influenza D virus.
    J Virol. 2019 Nov 27. pii: JVI.01662-19. doi: 10.1128/JVI.01662.
    PubMed     Abstract available


  82. KARAKUS U, Pohl MO, Stertz S
    Breaking the convention: Sialoglycan variants, Co-receptors and Alternative Receptors for Influenza A Virus Entry.
    J Virol. 2019 Nov 27. pii: JVI.01357-19. doi: 10.1128/JVI.01357.
    PubMed     Abstract available


  83. RODRIGUEZ-FRANDSEN A, Martin-Sancho L, Gounder AP, Chang MW, et al
    Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells.
    J Virol. 2019 Nov 27. pii: JVI.01410-19. doi: 10.1128/JVI.01410.
    PubMed     Abstract available


  84. SMITH A, Rodriguez L, Ghouayel ME, Nogales A, et al
    A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.
    J Virol. 2019 Nov 20. pii: JVI.01065-19. doi: 10.1128/JVI.01065.
    PubMed     Abstract available


  85. RIJAL P, Wang BB, Tan TK, Schimanski L, et al
    Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
    J Virol. 2019 Nov 20. pii: JVI.01182-19. doi: 10.1128/JVI.01182.
    PubMed     Abstract available


  86. MISTRY B, Long JS, Schreyer J, Staller E, et al
    Elucidating the interactions between influenza virus polymerase and host factor ANP32A.
    J Virol. 2019 Nov 6. pii: JVI.01353-19. doi: 10.1128/JVI.01353.
    PubMed     Abstract available


  87. WANG G, Jiang L, Wang J, Zhang J, et al
    The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry.
    J Virol. 2019 Nov 6. pii: JVI.01707-19. doi: 10.1128/JVI.01707.
    PubMed     Abstract available


  88. RUSSIER M, Yang G, Briard B, Meliopoulos V, et al
    HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.
    J Virol. 2019 Nov 6. pii: JVI.01423-19. doi: 10.1128/JVI.01423.
    PubMed     Abstract available


  89. HU B, Siche S, Moller L, Veit M, et al
    Amphipathic helices of cellular proteins can replace the helix in M2 of Influenza A virus with only small effects on virus replication.
    J Virol. 2019 Nov 6. pii: JVI.01605-19. doi: 10.1128/JVI.01605.
    PubMed     Abstract available


    October 2019
  90. KONG H, Ma S, Wang J, Gu C, et al
    Identification of key amino acids in the PB2 and M1 proteins of H7N9 influenza virus that affect its transmission in guinea pigs.
    J Virol. 2019 Oct 9. pii: JVI.01180-19. doi: 10.1128/JVI.01180.
    PubMed     Abstract available


  91. MONTEAGUDO PL, Munoz-Moreno R, Fribourg M, Potla U, et al
    Differential modulation of innate immune responses in human primary cells by influenza A viruses carrying human or avian non-structural 1 proteins.
    J Virol. 2019 Oct 9. pii: JVI.00999-19. doi: 10.1128/JVI.00999.
    PubMed     Abstract available


  92. HENSEN L, Matrosovich T, Roth K, Klenk HD, et al
    Hemagglutinin-dependent tropism of H5N1 and H7N9 influenza viruses to human endothelial cells is determined by reduced stability of the HA which allows the virus to cope with inefficient endosomal acidification and constitutively expressed IFITM3.
    J Virol. 2019 Oct 9. pii: JVI.01223-19. doi: 10.1128/JVI.01223.
    PubMed     Abstract available


  93. LAPORTE M, Stevaert A, Raeymaekers V, Boogaerts T, et al
    Hemagglutinin cleavability, acid-stability and temperature dependence optimize influenza B virus for replication in human airways.
    J Virol. 2019 Oct 9. pii: JVI.01430-19. doi: 10.1128/JVI.01430.
    PubMed     Abstract available


    September 2019
  94. GAO S, Zhang W, Lu C, Cao M, et al
    Identification of a type-specific promoter element that differentiates between influenza A and B viruses.
    J Virol. 2019 Sep 18. pii: JVI.01164-19. doi: 10.1128/JVI.01164.
    PubMed     Abstract available


  95. WASIK BR, Voorhees IEH, Barnard KN, Alford-Lawrence BK, et al
    Influenza Viruses in Mice: Deep Sequencing Analysis of Serial Passage and Effects of Sialic Acid Structural Variation.
    J Virol. 2019 Sep 11. pii: JVI.01039-19. doi: 10.1128/JVI.01039.
    PubMed     Abstract available


  96. YE L, Ohnemus A, Ong LC, Gad HH, et al
    Type I and type III interferons differ in their adjuvant activities for influenza vaccines.
    J Virol. 2019 Sep 11. pii: JVI.01262-19. doi: 10.1128/JVI.01262.
    PubMed     Abstract available


  97. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    PubMed     Abstract available


  98. BYRD-LEOTIS L, Gao C, Jia N, Mehta A, et al
    Antigenic pressure on H3N2 influenza drift strains imposes constraints on binding to sialylated receptors, but not phosphorylated glycans.
    J Virol. 2019 Sep 4. pii: JVI.01178-19. doi: 10.1128/JVI.01178.
    PubMed     Abstract available


  99. SOBEL LEONARD A, Weissman DB, Greenbaum B, Ghedin E, et al
    Correction for Sobel Leonard et al., "Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus".
    J Virol. 2019;93.
    PubMed    


    August 2019
  100. NAITO T, Shirai K, Mori K, Muratsu H, et al
    Tyr82 Amino Acid Mutation in PB1 Polymerase Induces an Influenza Virus Mutator Phenotype.
    J Virol. 2019 Aug 28. pii: JVI.00834-19. doi: 10.1128/JVI.00834.
    PubMed     Abstract available


  101. HENRY C, Palm AE, Utset HA, Huang M, et al
    Monoclonal antibody responses after recombinant HA vaccine versus subunit inactivated influenza virus vaccine: a comparative study.
    J Virol. 2019 Aug 21. pii: JVI.01150-19. doi: 10.1128/JVI.01150.
    PubMed     Abstract available


  102. YU J, Liu R, Zhou B, Chou TW, et al
    Development and characterization of a reverse genetics system for influenza D virus.
    J Virol. 2019 Aug 14. pii: JVI.01186-19. doi: 10.1128/JVI.01186.
    PubMed     Abstract available


  103. DHAKAL S, Klein SL
    Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs.
    J Virol. 2019 Aug 7. pii: JVI.00797-19. doi: 10.1128/JVI.00797.
    PubMed     Abstract available


  104. LIMBURG H, Harbig A, Bestle D, Stein DA, et al
    TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes.
    J Virol. 2019 Aug 7. pii: JVI.00649-19. doi: 10.1128/JVI.00649.
    PubMed     Abstract available


  105. MITRA S, Kumar D, Hu L, Sankaran B, et al
    Influenza A virus protein NS1 exhibits strain-independent conformational plasticity.
    J Virol. 2019 Aug 2. pii: JVI.00917-19. doi: 10.1128/JVI.00917.
    PubMed     Abstract available


  106. RAMOS I, Smith G, Ruf-Zamojski F, Martinez-Romero C, et al
    Innate immune response to influenza virus at single-cell resolution in human epithelial cells revealed paracrine induction of interferon lambda 1.
    J Virol. 2019 Aug 2. pii: JVI.00559-19. doi: 10.1128/JVI.00559.
    PubMed     Abstract available


  107. BROECKER F, Zheng A, Suntrongwong N, Sun W, et al
    Extending the stalk enhances immunogenicity of the influenza virus neuraminidase.
    J Virol. 2019 Aug 2. pii: JVI.00840-19. doi: 10.1128/JVI.00840.
    PubMed     Abstract available


    July 2019
  108. RATTAN A, Richards KA, Knowlden ZAG, Sant AJ, et al
    Protein vaccination directs the CD4+ T cell response towards shared protective epitopes that can be recalled after influenza infection.
    J Virol. 2019 Jul 24. pii: JVI.00947-19. doi: 10.1128/JVI.00947.
    PubMed     Abstract available


  109. KATAOKA M, Ishida K, Ogasawara K, Nozaki T, et al
    Serial Section Array Scanning Electron Microscopy Analysis of Cells from Lung Autopsy Specimens Following Fatal A/H1N1 2009 Pandemic Influenza Virus Infection.
    J Virol. 2019 Jul 10. pii: JVI.00644-19. doi: 10.1128/JVI.00644.
    PubMed     Abstract available


  110. LI X, Gao Y, Ye Z
    A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    J Virol. 2019 Jul 3. pii: JVI.00570-19. doi: 10.1128/JVI.00570.
    PubMed     Abstract available


  111. SUN X, Belser JA, Pappas C, Pulit-Penaloza JA, et al
    Correction for Sun et al., "Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models".
    J Virol. 2019;93.
    PubMed    


    June 2019
  112. STALLER E, Sheppard CM, Neasham PJ, Mistry B, et al
    ANP32 proteins are essential for influenza virus replication in human cells.
    J Virol. 2019 Jun 19. pii: JVI.00217-19. doi: 10.1128/JVI.00217.
    PubMed     Abstract available


  113. SINGANAYAGAM A, Zambon M, Barclay W
    Influenza virus with increased pH of HA activation has improved replication in cell culture but at the cost of infectivity in human airway epithelium.
    J Virol. 2019 Jun 12. pii: JVI.00058-19. doi: 10.1128/JVI.00058.
    PubMed     Abstract available


  114. KIM JI, Lee S, Lee GY, Park S, et al
    Novel small molecule targeting the hemagglutinin stalk of influenza viruses.
    J Virol. 2019 Jun 5. pii: JVI.00878-19. doi: 10.1128/JVI.00878.
    PubMed     Abstract available


    May 2019
  115. HU B, Hofer CT, Thiele C, Veit M, et al
    Cholesterol binding to the transmembrane region of a group 2 HA of Influenza virus is essential for virus replication affecting both virus assembly and HA's fusion activity.
    J Virol. 2019 May 22. pii: JVI.00555-19. doi: 10.1128/JVI.00555.
    PubMed     Abstract available


  116. YOUK SS, Lee DH, Leyson CM, Smith D, et al
    Loss of fitness in mallards of Mexican H7N3 highly pathogenic avian influenza virus after circulating in chickens.
    J Virol. 2019 May 8. pii: JVI.00543-19. doi: 10.1128/JVI.00543.
    PubMed     Abstract available


  117. RUSSELL AB, Elshina E, Kowalsky JR, Te Velthuis AJW, et al
    Single-cell virus sequencing of influenza infections that trigger innate immunity.
    J Virol. 2019 May 8. pii: JVI.00500-19. doi: 10.1128/JVI.00500.
    PubMed     Abstract available


  118. HUANG S, Zhu B, Cheon IS, Goplen NP, et al
    PPAR-gamma in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    J Virol. 2019;93.
    PubMed     Abstract available


  119. MCGINNES CULLEN L, Schmidt MR, Morrison TG
    Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    J Virol. 2019;93.
    PubMed     Abstract available


    April 2019
  120. MINO S, Mojsiejczuk L, Guo W, Zhang H, et al
    Equine influenza virus in Asia: phylogeographic pattern and molecular features revealed the circulation of an autochthonous lineage.
    J Virol. 2019 Apr 24. pii: JVI.00116-19. doi: 10.1128/JVI.00116.
    PubMed     Abstract available


  121. HOM N, Gentles L, Bloom JD, Lee KK, et al
    Deep mutational scan of the highly conserved influenza A M1 matrix protein reveals substantial intrinsic mutational tolerance.
    J Virol. 2019 Apr 24. pii: JVI.00161-19. doi: 10.1128/JVI.00161.
    PubMed     Abstract available


  122. WEBER A, Dam S, Saul VV, Kuznetsova I, et al
    Phosphoproteome analysis of cells infected with adapted and non-adapted influenza A virus reveals novel pro- and antiviral signaling networks.
    J Virol. 2019 Apr 17. pii: JVI.00528-19. doi: 10.1128/JVI.00528.
    PubMed     Abstract available


  123. GUAN M, Hall JS, Zhang X, Dusek RJ, et al
    Aerosol Transmission of Gull-Origin Iceland Subtype H10N7 Influenza A Virus in Ferrets.
    J Virol. 2019 Apr 17. pii: JVI.00282-19. doi: 10.1128/JVI.00282.
    PubMed     Abstract available


  124. ZHANG H, Zhang Z, Wang Y, Wang M, et al
    Fundamental contribution and host range determination of ANP32A and ANP32B in influenza A virus polymerase activity.
    J Virol. 2019 Apr 17. pii: JVI.00174-19. doi: 10.1128/JVI.00174.
    PubMed     Abstract available


  125. SUN W, Kirkpatrick E, Ermler M, Nachbagauer R, et al
    Development of Influenza B Universal Vaccine Candidates using the "Mosaic" Hemagglutinin Approach.
    J Virol. 2019 Apr 3. pii: JVI.00333-19. doi: 10.1128/JVI.00333.
    PubMed     Abstract available


    March 2019
  126. DREWS K, Calgi MP, Harrison WC, Drews CM, et al
    Glucosylceramidase Maintains Influenza Infection By Regulating Endocytosis.
    J Virol. 2019 Mar 27. pii: JVI.00017-19. doi: 10.1128/JVI.00017.
    PubMed     Abstract available


  127. SIEGERS JY, van de Bildt MWG, Lin Z, Leijten LM, et al
    Viral Factors Important for Efficient Replication of Influenza A Viruses in Cells of the Central Nervous System.
    J Virol. 2019 Mar 13. pii: JVI.02273-18. doi: 10.1128/JVI.02273.
    PubMed     Abstract available


  128. ALNAJI FG, Holmes JR, Rendon G, Vera JC, et al
    Sequencing framework for the sensitive detection and precise mapping of defective interfering particle-associated deletions across influenza A and B viruses.
    J Virol. 2019 Mar 13. pii: JVI.00354-19. doi: 10.1128/JVI.00354.
    PubMed     Abstract available


  129. NOGALES A, Avila-Perez G, Rangel-Moreno J, Chiem K, et al
    A novel fluorescent and bioluminescent Bi-Reporter influenza A virus (BIRFLU) to evaluate viral infections.
    J Virol. 2019 Mar 13. pii: JVI.00032-19. doi: 10.1128/JVI.00032.
    PubMed     Abstract available


    February 2019
  130. ZENG H, Goldsmith CS, Kumar A, Belser JA, et al
    Tropism and Infectivity of a Seasonal A(H1N1) and a Highly Pathogenic Avian A(H5N1) Influenza Virus in Primary Differentiated Ferret Nasal Epithelial Cell Cultures.
    J Virol. 2019 Feb 27. pii: JVI.00080-19. doi: 10.1128/JVI.00080.
    PubMed     Abstract available


  131. TANG YS, Lo CY, Mok CK, Chan PK, et al
    The extended C-terminal region of influenza C nucleoprotein is important for nuclear import and RNP activity.
    J Virol. 2019 Feb 27. pii: JVI.02048-18. doi: 10.1128/JVI.02048.
    PubMed     Abstract available


  132. JORQUERA PA, Mathew C, Pickens J, Williams C, et al
    Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro.
    J Virol. 2019;93.
    PubMed     Abstract available


  133. LIU G, Zhou Y
    Cytoplasm and Beyond: The Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.
    J Virol. 2019 Feb 13. pii: JVI.02299-18. doi: 10.1128/JVI.02299.
    PubMed     Abstract available


  134. TESINI BL, Kanagaiah P, Wang J, Hahn M, et al
    Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus.
    J Virol. 2019 Feb 6. pii: JVI.00169-19. doi: 10.1128/JVI.00169.
    PubMed     Abstract available


    January 2019
  135. CHRISTENSEN SR, Toulmin SA, Griesman T, Lamerato LE, et al
    Assessing the protective potential of H1N1 influenza virus hemagglutinin head and stalk antibodies in humans.
    J Virol. 2019 Jan 30. pii: JVI.02134-18. doi: 10.1128/JVI.02134.
    PubMed     Abstract available


  136. LINSTER M, Schrauwen EJA, van der Vliet S, Burke DF, et al
    The molecular basis for antigenic drift of human A/H2N2 influenza viruses.
    J Virol. 2019 Jan 30. pii: JVI.01907-18. doi: 10.1128/JVI.01907.
    PubMed     Abstract available


  137. SOUDANI N, Hage-Sleiman R, Karam W, Dbaibo G, et al
    Ceramide suppresses influenza A virus replication in vitro.
    J Virol. 2019 Jan 30. pii: JVI.00053-19. doi: 10.1128/JVI.00053.
    PubMed     Abstract available


  138. SALEM E, Hagglund S, Cassard H, Corre T, et al
    Pathogenesis, host innate immune response and aerosol transmission of Influenza D virus in cattle.
    J Virol. 2019 Jan 23. pii: JVI.01853-18. doi: 10.1128/JVI.01853.
    PubMed     Abstract available


  139. LIU S, Liu L, Xu G, Cao Z, et al
    Epigenetic modification is regulated by the interaction of influenza A virus nonstructural protein-1 with the de novo DNA methyltransferase DNMT3B and subsequent transport to the cytoplasm for K48-linked polyubiquitination.
    J Virol. 2019 Jan 16. pii: JVI.01587-18. doi: 10.1128/JVI.01587.
    PubMed     Abstract available


  140. DUBOIS J, Traversier A, Julien T, Padey B, et al
    The non-structural NS1 protein of influenza viruses modulates TP53 splicing through the host factor CPSF4.
    J Virol. 2019 Jan 16. pii: JVI.02168-18. doi: 10.1128/JVI.02168.
    PubMed     Abstract available


  141. LIANG B, Kabatova B, Kabat J, Dorward DW, et al
    Effects of alterations to the CX3C motif and secreted form of human respiratory syncytial virus (RSV) G protein on immune responses to a parainfluenza virus vector expressing the RSV G protein.
    J Virol. 2019 Jan 16. pii: JVI.02043-18. doi: 10.1128/JVI.02043.
    PubMed     Abstract available


  142. MANLEY GCA, Stokes CA, Marsh EK, Sabroe I, et al
    DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1beta Signaling.
    J Virol. 2019;93.
    PubMed     Abstract available


  143. LI ZT, Zarnitsyna VI, Lowen AC, Weissman D, et al
    Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?
    J Virol. 2019 Jan 9. pii: JVI.01534-18. doi: 10.1128/JVI.01534.
    PubMed     Abstract available


  144. ARUNKUMAR GA, Ioannou A, Wohlbold TJ, Meade P, et al
    Broadly cross-reactive, non-neutralizing antibodies against the influenza B virus hemagglutinin demonstrate effector function dependent protection against lethal viral challenge in mice.
    J Virol. 2019 Jan 9. pii: JVI.01696-18. doi: 10.1128/JVI.01696.
    PubMed     Abstract available


  145. MA JZ, Ng WC, Zappia L, Gearing LJ, et al
    Unique transcriptional architecture in airway epithelial cells and macrophages shapes distinct responses following influenza virus infection ex vivo.
    J Virol. 2019 Jan 9. pii: JVI.01986-18. doi: 10.1128/JVI.01986.
    PubMed     Abstract available


  146. LLOREN KKS, Kwon JJ, Choi WS, Jeong JH, et al
    In vitro and in vivo characterization of novel neuraminidase substitutions in influenza A(H1N1)pdm09 identified using Laninamivir-mediated in vitro selection.
    J Virol. 2019 Jan 2. pii: JVI.01825-18. doi: 10.1128/JVI.01825.
    PubMed     Abstract available


  147. LIU G, Lu Y, Liu Q, Zhou Y, et al
    Inhibition of Ongoing Influenza A Virus Replication Reveals Different Mechanisms of RIG-I Activation.
    J Virol. 2019 Jan 2. pii: JVI.02066-18. doi: 10.1128/JVI.02066.
    PubMed     Abstract available


    December 2018
  148. OBADAN AO, Santos J, Ferreri L, Thompson AJ, et al
    Flexibility in vitro of amino acid 226 in the receptor-binding site of an H9 subtype influenza A virus and its effect in vivo on virus replication, tropism, and transmission.
    J Virol. 2018 Dec 19. pii: JVI.02011-18. doi: 10.1128/JVI.02011.
    PubMed     Abstract available


  149. JEGASKANDA S, Vanderven HA, Tan HX, Alcantara S, et al
    Influenza infection enhances antibody-mediated NK cell functions via Type I interferon dependent pathways.
    J Virol. 2018 Dec 12. pii: JVI.02090-18. doi: 10.1128/JVI.02090.
    PubMed     Abstract available


  150. WANG R, Zhu Y, Zhao J, Ren C, et al
    Autophagy benefits the replication of influenza A virus in vitro.
    J Virol. 2018 Dec 12. pii: JVI.01984-18. doi: 10.1128/JVI.01984.
    PubMed     Abstract available


  151. KIMBLE JB, Malherbe DC, Meyer M, Gunn BM, et al
    ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE.
    J Virol. 2018 Dec 5. pii: JVI.01845-18. doi: 10.1128/JVI.01845.
    PubMed     Abstract available


  152. CHEN YQ, Lan LY, Huang M, Henry C, et al
    Hemagglutinin stalk-reactive antibodies interfere with influenza virus neuraminidase activity by steric hindrance.
    J Virol. 2018 Dec 5. pii: JVI.01526-18. doi: 10.1128/JVI.01526.
    PubMed     Abstract available


  153. CHEN H, Qian Y, Chen X, Ruan Z, et al
    HDAC6 restricts influenza A virus by deacetylation of the RNA polymerase PA subunit.
    J Virol. 2018 Dec 5. pii: JVI.01896-18. doi: 10.1128/JVI.01896.
    PubMed     Abstract available


    November 2018
  154. KUPKE SY, Riedel D, Frensing T, Zmora P, et al
    A novel type of influenza A virus-derived defective interfering particle with nucleotide substitutions in its genome.
    J Virol. 2018 Nov 21. pii: JVI.01786-18. doi: 10.1128/JVI.01786.
    PubMed     Abstract available


  155. JIANG M, Osterlund P, Westenius V, Guo D, et al
    Efficient inhibition of avian and seasonal influenza A viruses by a virus-specific Dicer-substrate siRNA swarm in human monocyte-derived macrophages and dendritic cells.
    J Virol. 2018 Nov 21. pii: JVI.01916-18. doi: 10.1128/JVI.01916.
    PubMed     Abstract available


  156. BOLTE H, Rosu ME, Hagelauer E, Garcia-Sastre A, et al
    Packaging of the influenza A virus genome is governed by a plastic network of RNA/protein interactions.
    J Virol. 2018 Nov 21. pii: JVI.01861-18. doi: 10.1128/JVI.01861.
    PubMed     Abstract available


  157. ARAI Y, Ibrahim MS, Elgendy EM, Daidoji T, et al
    Genetic compatibility of reassortants between avian H5N1 and H9N2 influenza viruses with higher pathogenicity in mammals.
    J Virol. 2018 Nov 21. pii: JVI.01969-18. doi: 10.1128/JVI.01969.
    PubMed     Abstract available


  158. CHOI EJ, Ren Y, Chen Y, Liu S, et al
    Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
    J Virol. 2018;92.
    PubMed     Abstract available


  159. ALLEN JD, Jang H, DiNapoli J, Kleanthous H, et al
    Elicitation of protective antibodies against 20 years of future H3N2 co-ciruculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses.
    J Virol. 2018 Nov 14. pii: JVI.00946-18. doi: 10.1128/JVI.00946.
    PubMed     Abstract available


    October 2018
  160. KANDEIL A, Gomaa MR, Shehata MM, El Taweel AN, et al
    Isolation and characterization of a distinct influenza A virus from Egyptian bats.
    J Virol. 2018 Oct 31. pii: JVI.01059-18. doi: 10.1128/JVI.01059.
    PubMed     Abstract available


  161. HUSSAIN S, Turnbull ML, Wise HM, Jagger BW, et al
    Mutation of influenza A virus PA-X decreases pathogenicity in chicken embryos and can increase the yield of reassortant candidate vaccine viruses.
    J Virol. 2018 Oct 31. pii: JVI.01551-18. doi: 10.1128/JVI.01551.
    PubMed     Abstract available


  162. SUN W, Kang DS, Zheng A, Liu STH, et al
    Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans.
    J Virol. 2018 Oct 31. pii: JVI.01673-18. doi: 10.1128/JVI.01673.
    PubMed     Abstract available


  163. MELIOPOULOS V, Livingston B, Van de Velde LA, Honce R, et al
    Absence of beta6 integrin reduces influenza disease severity in highly susceptible obese mice.
    J Virol. 2018 Oct 31. pii: JVI.01646-18. doi: 10.1128/JVI.01646.
    PubMed     Abstract available


  164. PRACHANRONARONG KL, Canale AS, Liu P, Somasundaran M, et al
    Mutations in influenza A virus neuraminidase and hemagglutinin confer resistance against a broadly neutralizing hemagglutinin stem antibody.
    J Virol. 2018 Oct 31. pii: JVI.01639-18. doi: 10.1128/JVI.01639.
    PubMed     Abstract available


  165. GOLDHILL DH, Langat P, Xie H, Galiano M, et al
    Determining the Mutation Bias of Favipiravir in Influenza Using Next-generation Sequencing.
    J Virol. 2018 Oct 31. pii: JVI.01217-18. doi: 10.1128/JVI.01217.
    PubMed     Abstract available


  166. AN Y, Parsons LM, Jankowska E, Melnyk D, et al
    N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for potency testing and immune processing.
    J Virol. 2018 Oct 24. pii: JVI.01693-18. doi: 10.1128/JVI.01693.
    PubMed     Abstract available


  167. DORNFELD D, Petric PP, Hassan E, Zell R, et al
    Eurasian avian-like swine influenza A viruses escape human MxA restriction by distinct mutations in their nucleoprotein.
    J Virol. 2018 Oct 24. pii: JVI.00997-18. doi: 10.1128/JVI.00997.
    PubMed     Abstract available


  168. GABA A, Xu F, Lu Y, Park HS, et al
    THE NS1 PROTEIN OF INFLUENZA A VIRUS PARTICIPATES IN NECROPTOSIS BY INTERACTING WITH MLKL AND INCREASING ITS OLIGOMERIZATION AND MEMBRANE TRANSLOCATION.
    J Virol. 2018 Oct 24. pii: JVI.01835-18. doi: 10.1128/JVI.01835.
    PubMed     Abstract available


  169. SANTOS JJS, Abente EJ, Obadan AO, Thompson AJ, et al
    Plasticity of amino acid residue 145 near the receptor binding site of H3 swine influenza A viruses and its impact on receptor binding and antibody recognition.
    J Virol. 2018 Oct 24. pii: JVI.01413-18. doi: 10.1128/JVI.01413.
    PubMed     Abstract available


  170. SUN X, Belser JA, Pappas C, Pulit-Penaloza JA, et al
    Risk assessment of fifth-wave H7N9 influenza A viruses in mammalian models.
    J Virol. 2018 Oct 10. pii: JVI.01740-18. doi: 10.1128/JVI.01740.
    PubMed     Abstract available


  171. TOME-AMAT J, Ramos I, Amanor F, Fernandez-Sesma A, et al
    Influenza A virus utilizes low affinity, high avidity interactions with the nuclear import machinery to ensure infection and immune evasion.
    J Virol. 2018 Oct 10. pii: JVI.01046-18. doi: 10.1128/JVI.01046.
    PubMed     Abstract available


  172. CHANG P, Sealy JE, Sadeyen JR, Iqbal M, et al
    Amino acid residue 217 in the hemagglutinin glycoprotein is a key mediator of avian influenza H7N9 virus antigenicity.
    J Virol. 2018 Oct 3. pii: JVI.01627-18. doi: 10.1128/JVI.01627.
    PubMed     Abstract available


  173. JANG Y, Shin JS, Yoon YS, Go YY, et al
    Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
    J Virol. 2018 Oct 3. pii: JVI.01441-18. doi: 10.1128/JVI.01441.
    PubMed     Abstract available


  174. FAY EJ, Aron SL, Stone IA, Waring BM, et al
    Engineered small molecule control of influenza A virus replication.
    J Virol. 2018 Oct 3. pii: JVI.01677-18. doi: 10.1128/JVI.01677.
    PubMed     Abstract available


  175. KUMAR A, Kumar A, Ingle H, Kumar S, et al
    MicroRNA hsa-miR-324-5p Suppresses H5N1 Virus Replication by Targeting the Viral PB1 and Host CUEDC2.
    J Virol. 2018;92.
    PubMed     Abstract available


    September 2018
  176. ZHANG L, Wang J, Munoz-Moreno R, Kim M, et al
    Influenza Virus NS1 Protein RNA-Interactome Reveals Intron Targeting.
    J Virol. 2018 Sep 26. pii: JVI.01634-18. doi: 10.1128/JVI.01634.
    PubMed     Abstract available


  177. GONZALEZ AJ, Ijezie EC, Balemba OB, Miura TA, et al
    Attenuation of influenza A virus disease severity by viral co-infection in a mouse model.
    J Virol. 2018 Sep 19. pii: JVI.00881-18. doi: 10.1128/JVI.00881.
    PubMed     Abstract available


  178. YANG C, Liu X, Gao Q, Cheng T, et al
    The nucleolar protein LYAR facilitates ribonucleoprotein assembly of influenza A virus.
    J Virol. 2018 Sep 12. pii: JVI.01042-18. doi: 10.1128/JVI.01042.
    PubMed     Abstract available


  179. DARRICARRERE N, Pougatcheva S, Duan X, Rudicell RS, et al
    Development of a Pan-H1 Influenza Vaccine.
    J Virol. 2018 Sep 5. pii: JVI.01349-18. doi: 10.1128/JVI.01349.
    PubMed     Abstract available


  180. ABENTE EJ, Rajao DS, Santos J, Kaplan BS, et al
    Comparison of adjuvanted-whole inactivated virus and live-attenuated virus vaccines against challenge with contemporary, antigenically distinct swine H3N2 influenza A viruses.
    J Virol. 2018 Sep 5. pii: JVI.01323-18. doi: 10.1128/JVI.01323.
    PubMed     Abstract available


  181. WESSELS U, Abdelwhab EM, Veits J, Hoffmann D, et al
    A Dual Motif in the Hemagglutinin of H5N1 Goose/Guangdong-Like Highly Pathogenic Avian Influenza Virus Strains Is Conserved from Their Early Evolution and Increases both Membrane Fusion pH and Virulence.
    J Virol. 2018;92.
    PubMed     Abstract available


    August 2018
  182. PULIT-PENALOZA JA, Pappas C, Belser JA, Sun X, et al
    Comparative in vitro and in vivo analysis of H1N1 and H1N2 variant influenza viruses isolated from humans between 2011 and 2016.
    J Virol. 2018 Aug 29. pii: JVI.01444-18. doi: 10.1128/JVI.01444.
    PubMed     Abstract available


  183. WOHLGEMUTH N, Lane AP, Pekosz A
    Influenza A virus M2 protein apical targeting is required for efficient virus replication.
    J Virol. 2018 Aug 29. pii: JVI.01425-18. doi: 10.1128/JVI.01425.
    PubMed     Abstract available


  184. WAN Z, Cardenas Garcia S, Liu J, Santos J, et al
    An alternative strategy as a quadrivalent live attenuated influenza virus vaccine.
    J Virol. 2018 Aug 22. pii: JVI.01025-18. doi: 10.1128/JVI.01025.
    PubMed     Abstract available


  185. HANCOCK AS, Stairiker CJ, Boesteanu AC, Monzon-Casanova E, et al
    Transcriptome analysis of infected and bystander type 2 alveolar epithelial cells during influenza A virus infection reveals in vivo Wnt pathway downregulation.
    J Virol. 2018 Aug 15. pii: JVI.01325-18. doi: 10.1128/JVI.01325.
    PubMed     Abstract available


  186. DU W, Dai M, Li Z, Boons GJ, et al
    Substrate binding by the 2(nd) sialic acid-binding site of influenza A virus N1 neuraminidase contributes to enzymatic activity.
    J Virol. 2018 Aug 8. pii: JVI.01243-18. doi: 10.1128/JVI.01243.
    PubMed     Abstract available


  187. HILLYER P, Shepard R, Uehling M, Krenz M, et al
    Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control.
    J Virol. 2018;92.
    PubMed     Abstract available


  188. KIM YJ, Kim KH, Ko EJ, Kim MC, et al
    Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain Specific HA or Cross Protective M2e vaccination.
    J Virol. 2018 Aug 1. pii: JVI.00969-18. doi: 10.1128/JVI.00969.
    PubMed     Abstract available


    July 2018
  189. BROECKER F, Liu STH, Sun W, Krammer F, et al
    Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    J Virol. 2018 Jul 25. pii: JVI.01100-18. doi: 10.1128/JVI.01100.
    PubMed     Abstract available


  190. LI L, Bowman AS, DeLiberto TJ, Killian ML, et al
    Genetic evidence supports sporadic and independent introductions of subtype H5 low pathogenic avian influenza A viruses from wild birds to domestic poultry in North America.
    J Virol. 2018 Jul 25. pii: JVI.00913-18. doi: 10.1128/JVI.00913.
    PubMed     Abstract available


  191. DAVIS AKF, McCormick K, Gumina ME, Petrie JG, et al
    Sera from individuals with narrowly focused influenza virus antibodies rapidly select viral escape mutations in ovo.
    J Virol. 2018 Jul 25. pii: JVI.00859-18. doi: 10.1128/JVI.00859.
    PubMed     Abstract available


  192. NOGALES A, Martinez-Sobrido L, Chiem K, Topham DJ, et al
    FUNCTIONAL EVOLUTION OF THE 2009 PANDEMIC H1N1 INFLUENZA NS1 AND PA IN HUMANS.
    J Virol. 2018 Jul 18. pii: JVI.01206-18. doi: 10.1128/JVI.01206.
    PubMed     Abstract available


  193. WEN F, Blackmon S, Olivier AK, Li L, et al
    Mutation W222L at the receptor binding site of hemagglutinin could facilitate viral adaption from equine influenza A(H3N8) virus to dogs.
    J Virol. 2018 Jul 11. pii: JVI.01115-18. doi: 10.1128/JVI.01115.
    PubMed     Abstract available


  194. FABOZZI G, Oler AJ, Liu P, Chen Y, et al
    Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions.
    J Virol. 2018 Jul 5. pii: JVI.00518-18. doi: 10.1128/JVI.00518.
    PubMed     Abstract available


    June 2018
  195. ZHAO M, Chen J, Tan S, Dong T, et al
    Prolonged evolution of virus-specific memory T cell immunity post severe avian influenza A (H7N9) virus infection.
    J Virol. 2018 Jun 20. pii: JVI.01024-18. doi: 10.1128/JVI.01024.
    PubMed     Abstract available


  196. LIN Q, Li T, Chen Y, Lau SY, et al
    Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus.
    J Virol. 2018 Jun 20. pii: JVI.00547-18. doi: 10.1128/JVI.00547.
    PubMed     Abstract available


  197. WALZ L, Kays SK, Zimmer G, von Messling V, et al
    Sialidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    J Virol. 2018 Jun 20. pii: JVI.01006-18. doi: 10.1128/JVI.01006.
    PubMed     Abstract available


  198. CAI H, Liu M, Russell CJ
    Directed evolution of an influenza reporter virus to restore replication and virulence and enhance non-invasive bioluminescence imaging in mice.
    J Virol. 2018 Jun 13. pii: JVI.00593-18. doi: 10.1128/JVI.00593.
    PubMed     Abstract available


  199. NACHBAGAUER R, Shore D, Yang H, Johnson SK, et al
    Broadly-reactive human monoclonal antibodies elicited following pandemic H1N1 influenza virus exposure protect mice from highly pathogenic H5N1 challenge.
    J Virol. 2018 Jun 13. pii: JVI.00949-18. doi: 10.1128/JVI.00949.
    PubMed     Abstract available


  200. FULTON BO, Sun W, Heaton NS, Palese P, et al
    The influenza B virus hemagglutinin head domain is less tolerant to transposon mutagenesis than that of the influenza A virus.
    J Virol. 2018 Jun 13. pii: JVI.00754-18. doi: 10.1128/JVI.00754.
    PubMed     Abstract available


  201. PATIL G, Zhao M, Song K, Hao W, et al
    TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection.
    J Virol. 2018 Jun 13. pii: JVI.00905-18. doi: 10.1128/JVI.00905.
    PubMed     Abstract available


  202. CHAI W, Li J, Shangguan Q, Liu Q, et al
    Lnc-ISG20 inhibits influenza A virus replication by enhancing ISG20 expression.
    J Virol. 2018 Jun 13. pii: JVI.00539-18. doi: 10.1128/JVI.00539.
    PubMed     Abstract available


  203. WONG FYK, Donato C, Deng YM, Teng D, et al
    Divergent human origin influenza viruses detected in Australian swine populations.
    J Virol. 2018 Jun 6. pii: JVI.00316-18. doi: 10.1128/JVI.00316.
    PubMed     Abstract available


  204. NILSSON-PAYANT BE, Sharps J, Hengrung N, Fodor E, et al
    The surface-exposed PA(51-72)-loop of the influenza A virus polymerase is required for viral genome replication.
    J Virol. 2018 Jun 6. pii: JVI.00687-18. doi: 10.1128/JVI.00687.
    PubMed     Abstract available


  205. VOORHEES IEH, Dalziel BD, Glaser A, Dubovi EJ, et al
    Multiple incursions and recurrent epidemic fade-out of H3N2 canine influenza A virus in the United States.
    J Virol. 2018 Jun 6. pii: JVI.00323-18. doi: 10.1128/JVI.00323.
    PubMed     Abstract available


  206. TIAN B, Yang J, Zhao Y, Ivanciuc T, et al
    Central Role of the NF-kappaB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation.
    J Virol. 2018;92.
    PubMed     Abstract available


    May 2018
  207. YANG H, Carney PJ, Chang JC, Guo Z, et al
    Structural and Molecular Characterization of the Hemagglutinin from the Fifth Epidemic Wave A(H7N9) Influenza Viruses.
    J Virol. 2018 May 30. pii: JVI.00375-18. doi: 10.1128/JVI.00375.
    PubMed     Abstract available


  208. SUN X, Pulit-Penaloza JA, Belser JA, Pappas C, et al
    Pathogenesis and transmission of genetically diverse swine-origin H3N2v influenza A viruses from multiple lineages isolated in the United States, 2011-2016.
    J Virol. 2018 May 30. pii: JVI.00665-18. doi: 10.1128/JVI.00665.
    PubMed     Abstract available


  209. VENKATESH D, Poen MJ, Bestebroer TM, Scheuer RD, et al
    Avian influenza viruses in wild birds: virus evolution in a multi-host ecosystem.
    J Virol. 2018 May 16. pii: JVI.00433-18. doi: 10.1128/JVI.00433.
    PubMed     Abstract available


  210. PENG W, Bouwman KM, McBride R, Grant OC, et al
    Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation.
    J Virol. 2018;92.
    PubMed     Abstract available


  211. LEE S, Hirohama M, Noguchi M, Nagata K, et al
    Influenza A virus infection triggers pyroptosis and apoptosis of respiratory epithelial cells through type I IFN signaling pathway in a mutually exclusive manner.
    J Virol. 2018 May 9. pii: JVI.00396-18. doi: 10.1128/JVI.00396.
    PubMed     Abstract available


    April 2018
  212. DIPIAZZA A, Laniewski N, Rattan A, Topham DJ, et al
    CD4 T cell epitope specificity and cytokine potential are preserved as cells transition from the lung vasculature to lung tissue following influenza infection.
    J Virol. 2018 Apr 18. pii: JVI.00377-18. doi: 10.1128/JVI.00377.
    PubMed     Abstract available


  213. SUN H, Blackmon S, Yang G, Waters K, et al
    Erratum for Sun et al., "Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus".
    J Virol. 2018;92.
    PubMed    


  214. LI M, Li J, Zeng R, Yang J, et al
    Respiratory Syncytial Virus Replication Is Promoted by Autophagy-Mediated Inhibition of Apoptosis.
    J Virol. 2018;92.
    PubMed     Abstract available


  215. BAE JY, Lee I, Kim JI, Park S, et al
    A Single Amino Acid at the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.
    J Virol. 2018 Apr 11. pii: JVI.00259-18. doi: 10.1128/JVI.00259.
    PubMed     Abstract available


    March 2018
  216. WANG W, Song HS, Keller PW, Alvarado-Facundo E, et al
    Conformational stability of the hemagglutinin of H5N1 influenza A viruses influences susceptibility to broadly neutralizing stem antibodies.
    J Virol. 2018 Mar 28. pii: JVI.00247-18. doi: 10.1128/JVI.00247.
    PubMed     Abstract available


  217. VAN DE SANDT CE, Pronk MR, van Baalen CA, Fouchier RAM, et al
    Variation at extra-epitopic amino acid residues influences suppression of influenza virus replication by M158-66 epitope-specific CD8(+) T lymphocytes.
    J Virol. 2018 Mar 28. pii: JVI.00232-18. doi: 10.1128/JVI.00232.
    PubMed     Abstract available


  218. QUAN C, Shi W, Yang Y, Yang Y, et al
    New threats of H7N9 influenza virus: the spread and evolution of highly and low pathogenic variants with high genomic diversity in Wave Five.
    J Virol. 2018 Mar 21. pii: JVI.00301-18. doi: 10.1128/JVI.00301.
    PubMed     Abstract available


  219. WATANABE Y, Arai Y, Kawashita N, Ibrahim MS, et al
    Characterization of H5N1 influenza virus quasispecies with adaptive hemagglutinin mutations from single-virus infections of human airway cells.
    J Virol. 2018 Mar 21. pii: JVI.02004-17. doi: 10.1128/JVI.02004.
    PubMed     Abstract available


  220. ALJURAYYAN A, Puksuriwong S, Ahmed M, Sharma R, et al
    Activation and induction of antigen-specific T follicular helper cells (TFH) play a critical role in LAIV-induced human mucosal anti-influenza antibody response.
    J Virol. 2018 Mar 21. pii: JVI.00114-18. doi: 10.1128/JVI.00114.
    PubMed     Abstract available


  221. WANG J, Zeng Y, Xu S, Yang J, et al
    A Naturally Occurring Deletion in the Effector Domain of H5N1 Swine Influenza Virus Nonstructural Protein 1 Regulates Viral Fitness and Host Innate Immunity.
    J Virol. 2018 Mar 21. pii: JVI.00149-18. doi: 10.1128/JVI.00149.
    PubMed     Abstract available


  222. MAZEL-SANCHEZ B, Boal Carvalho I, Silva F, Dijkman R, et al
    H5N1 influenza A virus PB1-F2 relieves HAX-1-mediated restriction of avian virus polymerase PA in human lung cells.
    J Virol. 2018 Mar 21. pii: JVI.00425-18. doi: 10.1128/JVI.00425.
    PubMed     Abstract available


  223. NIEMEYER BF, Oko LM, Medina EM, Oldenburg DG, et al
    Host Tumor Suppressor p18(INK4c) Functions as a Potent Cell-Intrinsic Inhibitor of Murine Gammaherpesvirus 68 Reactivation and Pathogenesis.
    J Virol. 2018;92.
    PubMed     Abstract available


  224. PULIT-PENALOZA JA, Jones J, Sun X, Jang Y, et al
    Antigenically diverse swine-origin H1N1 variant influenza viruses exhibit differential ferret pathogenesis and transmission phenotypes.
    J Virol. 2018 Mar 14. pii: JVI.00095-18. doi: 10.1128/JVI.00095.
    PubMed     Abstract available


  225. WAN Y, Kang G, Sreenivasan C, Daharsh L, et al
    A DNA vaccine expressing consensus hemagglutinin-esterase fusion protein protected guinea pigs from infection by two lineages of influenza D virus.
    J Virol. 2018 Mar 7. pii: JVI.00110-18. doi: 10.1128/JVI.00110.
    PubMed     Abstract available


  226. AGGARWAL M, Leser GP, Kors CA, Lamb RA, et al
    Structure of the Paramyxovirus Parainfluenza Virus 5 Nucleoprotein in Complex with an Amino-Terminal Peptide of the Phosphoprotein.
    J Virol. 2018;92.
    PubMed     Abstract available


    February 2018
  227. JEGASKANDA S, Mason RD, Andrews SF, Wheatley AK, et al
    Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes.
    J Virol. 2018 Feb 14. pii: JVI.01970-17. doi: 10.1128/JVI.01970.
    PubMed     Abstract available


  228. TRIPP RA, Power UF, Openshaw PJM, Kauvar LM, et al
    Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem.
    J Virol. 2018;92.
    PubMed     Abstract available


    January 2018
  229. PARK HS, Liu G, Thulasi Raman SN, Landreth SL, et al
    NS1 protein of 2009 pandemic influenza A virus inhibits porcine NLRP3 inflammasome-mediated interleukin-1 beta production by suppressing ASC ubiquitination.
    J Virol. 2018 Jan 31. pii: JVI.00022-18. doi: 10.1128/JVI.00022.
    PubMed     Abstract available


  230. XIA C, Wolf JJ, Vijayan M, Studstill CJ, et al
    Casein kinase 1alpha mediates degradation of receptors for type I and type II interferons caused by hemagglutinin of influenza A virus.
    J Virol. 2018 Jan 17. pii: JVI.00006-18. doi: 10.1128/JVI.00006.
    PubMed     Abstract available


  231. FOX CR, Parks GD
    Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA Damaging Agents: Implications for Oncolytic Virus Therapy.
    J Virol. 2018 Jan 17. pii: JVI.01948-17. doi: 10.1128/JVI.01948.
    PubMed     Abstract available


  232. NAKATSU S, Murakami S, Shindo K, Horimoto T, et al
    Influenza C and D viruses package eight organized ribonucleoprotein complexes.
    J Virol. 2018 Jan 10. pii: JVI.02084-17. doi: 10.1128/JVI.02084.
    PubMed     Abstract available


  233. AYDILLO T, Ayllon J, Pavlisin A, Martinez-Romero C, et al
    Specific mutations in the PB2 protein of influenza A virus compensate for the lack of efficient IFN antagonism of the NS1 protein of bat influenza A-like viruses.
    J Virol. 2018 Jan 10. pii: JVI.02021-17. doi: 10.1128/JVI.02021.
    PubMed     Abstract available


  234. CREAGER HM, Kumar A, Zeng H, Maines TR, et al
    Infection and replication of influenza virus at the ocular surface.
    J Virol. 2018 Jan 10. pii: JVI.02192-17. doi: 10.1128/JVI.02192.
    PubMed     Abstract available


  235. VER LS, Marcos-Villar L, Landeras-Bueno S, Nieto A, et al
    Correction for Ver et al., "The Cellular Factor NXP2/MORC3 Is a Positive Regulator of Influenza Virus Multiplication".
    J Virol. 2017;92.
    PubMed    


    December 2017
  236. WILLIAMS JA, Gui L, Hom N, Mileant A, et al
    Dissection of epitope-specific mechanisms of neutralization of influenza virus by intact IgG and Fab fragments.
    J Virol. 2017 Dec 20. pii: JVI.02006-17. doi: 10.1128/JVI.02006.
    PubMed     Abstract available


  237. CHAUCHE C, Nogales A, Zhu H, Goldfarb D, et al
    Mammalian adaptation of an avian influenza A virus involves stepwise changes in NS1.
    J Virol. 2017 Dec 13. pii: JVI.01875-17. doi: 10.1128/JVI.01875.
    PubMed     Abstract available


  238. TURKINGTON HL, Juozapaitis M, Tsolakos N, Corrales-Aguilar E, et al
    Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
    J Virol. 2017 Dec 13. pii: JVI.02097-17. doi: 10.1128/JVI.02097.
    PubMed     Abstract available


  239. CHEN C, Liu L, Xiao Y, Cui S, et al
    Structural insight into a human neutralizing antibody against influenza virus H7N9.
    J Virol. 2017 Dec 6. pii: JVI.01850-17. doi: 10.1128/JVI.01850.
    PubMed     Abstract available


  240. RICHARD M, Herfst S, Tao H, Jacobs NT, et al
    Influenza A virus reassortment is limited by anatomical compartmentalization following co-infection via distinct routes.
    J Virol. 2017 Dec 6. pii: JVI.02063-17. doi: 10.1128/JVI.02063.
    PubMed     Abstract available


  241. XIAO J, Rijal P, Schimanski L, Tharkeshwar AK, et al
    Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.
    J Virol. 2017 Dec 6. pii: JVI.00941-17. doi: 10.1128/JVI.00941.
    PubMed     Abstract available


  242. ZHONG G, Le MQ, Lopes TJS, Halfmann P, et al
    Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.
    J Virol. 2017 Dec 6. pii: JVI.01557-17. doi: 10.1128/JVI.01557.
    PubMed     Abstract available


  243. IWATSUKI-HORIMOTO K, Nakajima N, Ichiko Y, Sakai-Tagawa Y, et al
    Syrian hamster as an animal model for the study of human influenza virus infection.
    J Virol. 2017 Dec 6. pii: JVI.01693-17. doi: 10.1128/JVI.01693.
    PubMed     Abstract available


  244. YANG L, Zhu W, Li X, Chen M, et al
    Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.
    J Virol. 2017;91.
    PubMed     Abstract available


    November 2017
  245. SHIL NK, Pokharel SM, Banerjee AK, Hoffman M, et al
    Inflammasome antagonism by human parainfluenza virus type 3 C protein.
    J Virol. 2017 Nov 29. pii: JVI.01776-17. doi: 10.1128/JVI.01776.
    PubMed     Abstract available


  246. WAN H, Qi L, Gao J, Couzens LK, et al
    Comparison of the Efficacy of N9 Neuraminidase-specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    J Virol. 2017 Nov 22. pii: JVI.01588-17. doi: 10.1128/JVI.01588.
    PubMed     Abstract available


  247. SU WC, Yu WY, Huang SH, Lai MMC, et al
    Ubiquitination of the Cytoplasmic Domain of Influenza A Virus M2 Protein is Crucial for Production of Infectious Virus Particles.
    J Virol. 2017 Nov 22. pii: JVI.01972-17. doi: 10.1128/JVI.01972.
    PubMed     Abstract available


  248. JOB ER, Schotsaert M, Ibanez LI, Smet A, et al
    Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.
    J Virol. 2017 Nov 22. pii: JVI.01584-17. doi: 10.1128/JVI.01584.
    PubMed     Abstract available


  249. TE VELTHUIS AJW, Oymans J
    Initiation, elongation and realignment during influenza virus mRNA synthesis.
    J Virol. 2017 Nov 15. pii: JVI.01775-17. doi: 10.1128/JVI.01775.
    PubMed     Abstract available


  250. SAKAI T, Takagi H, Muraki Y, Saito M, et al
    Unique directional motility of influenza C virus controlled by its filamentous morphology and short-range motions.
    J Virol. 2017 Nov 8. pii: JVI.01522-17. doi: 10.1128/JVI.01522.
    PubMed     Abstract available


  251. OYMANS J, Te Velthuis AJW
    A mechanism for prime-realignment during influenza A virus replication.
    J Virol. 2017 Nov 8. pii: JVI.01773-17. doi: 10.1128/JVI.01773.
    PubMed     Abstract available


  252. WEN F, Li L, Zhao N, Chiang MJ, et al
    A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 influenza A Virus in Cells.
    J Virol. 2017 Nov 8. pii: JVI.01621-17. doi: 10.1128/JVI.01621.
    PubMed     Abstract available


  253. WARING BM, Sjaastad LE, Fiege JK, Fay EJ, et al
    microRNA-based attenuation of influenza virus across susceptible hosts.
    J Virol. 2017 Nov 1. pii: JVI.01741-17. doi: 10.1128/JVI.01741.
    PubMed     Abstract available


  254. VAN ERP EA, van Kasteren PB, Guichelaar T, Ahout IML, et al
    In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.
    J Virol. 2017;91.
    PubMed     Abstract available


    October 2017
  255. QI W, Jia W, Liu D, Li J, et al
    Emergence and adaptation of a novel highly pathogenic H7N9 influenza virus in birds and humans from a 2013-human-infecting low pathogenic ancestor.
    J Virol. 2017 Oct 25. pii: JVI.00921-17. doi: 10.1128/JVI.00921.
    PubMed     Abstract available


  256. CHOI WS, Jeong JH, Kwon JJ, Ahn SJ, et al
    Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6 and N8 Neuraminidase Subtypes.
    J Virol. 2017 Oct 18. pii: JVI.01580-17. doi: 10.1128/JVI.01580.
    PubMed     Abstract available


  257. LIU H, Grantham ML, Pekosz A
    Mutations in the Influenza A virus M1 protein enhance virus budding to complement lethal mutations in the M2 cytoplasmic tail.
    J Virol. 2017 Oct 18. pii: JVI.00858-17. doi: 10.1128/JVI.00858.
    PubMed     Abstract available


  258. SUTTON TC, Lamirande EW, Bock KW, Moore IN, et al
    In vitro neutralization is not predictive of prophylactic efficacy of broadly neutralizing monoclonal antibodies CR6261 and CR9114 against lethal H2 influenza virus challenge in mice.
    J Virol. 2017 Oct 18. pii: JVI.01603-17. doi: 10.1128/JVI.01603.
    PubMed     Abstract available


  259. FRABUTT DA, Wang B, Riaz S, Schwartz RC, et al
    Innate sensing of influenza A virus hemagglutinin glycoproteins by the host endoplasmic reticulum (ER) stress pathway triggers a potent antiviral response via ER-associated protein degradation.
    J Virol. 2017 Oct 18. pii: JVI.01690-17. doi: 10.1128/JVI.01690.
    PubMed     Abstract available


  260. WONG TM, Allen JD, Bebin-Blackwell AG, Carter DM, et al
    COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants.
    J Virol. 2017 Oct 4. pii: JVI.01581-17. doi: 10.1128/JVI.01581.
    PubMed     Abstract available


  261. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses.
    J Virol. 2017 Oct 4. pii: JVI.01283-17. doi: 10.1128/JVI.01283.
    PubMed     Abstract available


    September 2017
  262. MOONEY AJ, Gabbard JD, Li Z, Dlugolenski DA, et al
    Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    J Virol. 2017 Sep 20. pii: JVI.01579-17. doi: 10.1128/JVI.01579.
    PubMed     Abstract available


  263. ANDERSEN TK, Zhou F, Cox R, Bogen B, et al
    A DNA vaccine that targets hemagglutinin to antigen presenting cells protects mice against H7 influenza.
    J Virol. 2017 Sep 20. pii: JVI.01340-17. doi: 10.1128/JVI.01340.
    PubMed     Abstract available


  264. NAGUIB MM, Ulrich R, Kasbohm E, Eng CLP, et al
    Natural reassortants between potentially zoonotic avian influenza viruses H5N1 and H9N2 from Egypt display distinct pathogenic phenotypes in experimentally infected chickens and ferrets.
    J Virol. 2017 Sep 20. pii: JVI.01300-17. doi: 10.1128/JVI.01300.
    PubMed     Abstract available


  265. KEEF E, Zhang LA, Swigon D, Urbano A, et al
    Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity.
    J Virol. 2017 Sep 13. pii: JVI.00395-17. doi: 10.1128/JVI.00395.
    PubMed     Abstract available


  266. GOTO T, Shimotai Y, Matsuzaki Y, Muraki Y, et al
    Effect of the phosphorylation of the CM2 protein on influenza C virus replication.
    J Virol. 2017 Sep 6. pii: JVI.00773-17. doi: 10.1128/JVI.00773.
    PubMed     Abstract available


    August 2017
  267. BROOKE CB
    Population diversity and collective interactions during influenza virus replication and evolution.
    J Virol. 2017 Aug 30. pii: JVI.01164-17. doi: 10.1128/JVI.01164.
    PubMed     Abstract available


  268. NOGALES A, Chauche C, DeDiego ML, Topham DJ, et al
    Amino acid substitution K186E in the canine influenza virus H3N8 NS1 protein restores its ability to inhibit host gene expression.
    J Virol. 2017 Aug 23. pii: JVI.00877-17. doi: 10.1128/JVI.00877.
    PubMed     Abstract available


  269. LIU X, Liang B, Ngwuta J, Liu X, et al
    Attenuated human parainfluenza virus type 1 (HPIV1) expressing the respiratory syncytial virus (RSV) fusion F glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of RSV F.
    J Virol. 2017 Aug 23. pii: JVI.01101-17. doi: 10.1128/JVI.01101.
    PubMed     Abstract available


  270. LOPES AM, Domingues P, Zell R, Hale BG, et al
    Structure-Guided Functional Annotation of the Influenza A Virus NS1 Protein Reveals Dynamic Evolution of the p85beta-Binding Site During Circulation in Humans.
    J Virol. 2017 Aug 16. pii: JVI.01081-17. doi: 10.1128/JVI.01081.
    PubMed     Abstract available


  271. WANG Z, Yang H, Chen Y, Tao S, et al
    A Single-Amino-Acid Substitution at Position 225 in HA Alters the Transmissibility of Eurasian Avian-like H1N1 Swine Influenza Virus in Guinea Pigs.
    J Virol. 2017 Aug 16. pii: JVI.00800-17. doi: 10.1128/JVI.00800.
    PubMed     Abstract available


  272. SUN H, Blackmon S, Yang G, Waters K, et al
    Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
    J Virol. 2017 Aug 16. pii: JVI.00637-17. doi: 10.1128/JVI.00637.
    PubMed     Abstract available


  273. CHLANDA P, Mekhedov E, Waters H, Sodt A, et al
    Palmitoylation contributes to membrane curvature in Influenza A virus assembly and hemagglutinin-mediated membrane fusion.
    J Virol. 2017 Aug 9. pii: JVI.00947-17. doi: 10.1128/JVI.00947.
    PubMed     Abstract available


  274. BERTRAN K, Lee DH, Pantin-Jackwood MJ, Spackman E, et al
    Pathobiology of clade 2.3.4.4 H5Nx high pathogenicity avian influenza virus infections in minor gallinaceous poultry supports early backyard flock introductions in Western U.S., 2014-2015.
    J Virol. 2017 Aug 9. pii: JVI.00960-17. doi: 10.1128/JVI.00960.
    PubMed     Abstract available


  275. CHEN SC, Jeng KS, Lai MMC
    Zinc finger-containing cellular transcription corepressor ZBTB25 promotes influenza virus RNA transcription and is a target for zinc-ejector drugs.
    J Virol. 2017 Aug 2. pii: JVI.00842-17. doi: 10.1128/JVI.00842.
    PubMed     Abstract available


  276. KAMAL RP, Blanchfield K, Belser JA, Music N, et al
    Inactivated H7 influenza virus vaccines protect mice despite low levels of neutralizing antibodies.
    J Virol. 2017 Aug 2. pii: JVI.01202-17. doi: 10.1128/JVI.01202.
    PubMed     Abstract available


    July 2017
  277. PHAN SI, Zengel JR, Wei H, Li Z, et al
    Parainfluenza virus 5 (PIV5) expressing wild-type or pre-fusion respiratory syncytial virus (RSV) fusion protein protect mice and cotton rats from RSV challenge.
    J Virol. 2017 Jul 26. pii: JVI.00560-17. doi: 10.1128/JVI.00560.
    PubMed     Abstract available


  278. PHAN SI, Adam CM, Chen Z, Citron M, et al
    The genetic stability of PIV5-vectored RSV vaccine candidates after in vitro and in vivo passage.
    J Virol. 2017 Jul 26. pii: JVI.00559-17. doi: 10.1128/JVI.00559.
    PubMed     Abstract available


  279. NTURIBI E, Bhagwat AR, Coburn S, Myerburg MM, et al
    Intracellular Colocalization of Influenza Viral RNA and Rab11A is Dependent upon Microtubule Filaments.
    J Virol. 2017 Jul 19. pii: JVI.01179-17. doi: 10.1128/JVI.01179.
    PubMed     Abstract available


  280. SUTTON TC, Lamirande EW, Czako R, Subbarao K, et al
    Evaluation of the biological properties and cross-reactive antibody response to H10 influenza viruses in ferrets.
    J Virol. 2017 Jul 12. pii: JVI.00895-17. doi: 10.1128/JVI.00895.
    PubMed     Abstract available


    June 2017
  281. DIAZ A, Marthaler D, Culhane M, Sreevatsan S, et al
    Complete Genome Sequencing of Influenza A Viruses within Swine Farrow-to-Wean Farms Reveals the Emergence, Persistence, and Subsidence of Diverse Viral Genotypes.
    J Virol. 2017 Jun 28. pii: JVI.00745-17. doi: 10.1128/JVI.00745.
    PubMed     Abstract available


  282. PHIPPS KL, Marshall N, Tao H, Danzy S, et al
    Seasonal H3N2 and 2009 pandemic H1N1 influenza A viruses reassort efficiently but produce attenuated progeny.
    J Virol. 2017 Jun 21. pii: JVI.00830-17. doi: 10.1128/JVI.00830.
    PubMed     Abstract available


  283. CLARK AM, Nogales A, Martinez-Sobrido L, Topham DJ, et al
    Functional evolution of influenza NS1 protein in currently circulating human 2009 pandemic H1N1 viruses.
    J Virol. 2017 Jun 21. pii: JVI.00721-17. doi: 10.1128/JVI.00721.
    PubMed     Abstract available


  284. NOGALES A, Rodriguez L, DeDiego ML, Topham DJ, et al
    Interplay of PA-X and NS1 proteins in replication and pathogenesis of a temperature-sensitive 2009 pandemic H1N1 influenza A virus.
    J Virol. 2017 Jun 21. pii: JVI.00720-17. doi: 10.1128/JVI.00720.
    PubMed     Abstract available


  285. NILSSON BE, Te Velthuis AJW, Fodor E
    Erratum for Nilsson et al., "Role of the PB2 627 Domain in Influenza A Virus Polymerase Function".
    J Virol. 2017;91.
    PubMed    


  286. MAGNEN M, Gueugnon F, Guillon A, Baranek T, et al
    Kallikrein-related peptidase 5 contributes to H3N2 influenza virus infection in human lungs.
    J Virol. 2017 Jun 14. pii: JVI.00421-17. doi: 10.1128/JVI.00421.
    PubMed     Abstract available


  287. WANG D, Phan S, DiStefano DJ, Citron MP, et al
    A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    J Virol. 2017;91.
    PubMed     Abstract available


    May 2017
  288. ZHAO M, Zheng ZZ, Chen M, Modjarrad K, et al
    Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab.
    J Virol. 2017 May 24. pii: JVI.00176-17. doi: 10.1128/JVI.00176.
    PubMed     Abstract available


  289. PEREIRA CF, Read EKC, Wise HM, Amorim MJ, et al
    The influenza A virus NS1 protein promotes efficient nuclear export of unspliced viral M1 mRNA.
    J Virol. 2017 May 17. pii: JVI.00528-17. doi: 10.1128/JVI.00528.
    PubMed     Abstract available


  290. BELSER JA, Pulit-Penaloza JA, Sun X, Brock N, et al
    A novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model.
    J Virol. 2017 May 17. pii: JVI.00672-17. doi: 10.1128/JVI.00672.
    PubMed     Abstract available


  291. ZHANG L, Li H, Hai Y, Yin W, et al
    CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in
    J Virol. 2017;91.
    PubMed     Abstract available


  292. BOONNAK K, Matsuoka Y, Wang W, Suguitan AL Jr, et al
    Development of clade-specific and broadly reactive live attenuated influenza virus vaccines against rapidly evolving H5 subtype viruses.
    J Virol. 2017 May 10. pii: JVI.00547-17. doi: 10.1128/JVI.00547.
    PubMed     Abstract available


  293. FUCHS J, Holzer M, Schilling M, Patzina C, et al
    Evolution and antiviral specificity of interferon-induced Mx proteins of bats against Ebola-, Influenza-, and other RNA viruses.
    J Virol. 2017 May 10. pii: JVI.00361-17. doi: 10.1128/JVI.00361.
    PubMed     Abstract available


  294. WU Y, Wang J, Fan S, Chen R, et al
    Structural Definition of Duck MHC class I Molecules that might explain efficient CTL Immunity against Influenza A Virus.
    J Virol. 2017 May 10. pii: JVI.02511-16. doi: 10.1128/JVI.02511.
    PubMed     Abstract available


  295. PEACOCK TP, Benton DJ, James J, Sadeyen JR, et al
    Immune escape variants of H9N2 influenza viruses containing deletions at the haemagglutinin receptor binding site retain fitness in vivo and display enhanced zoonotic characteristics.
    J Virol. 2017 May 3. pii: JVI.00218-17. doi: 10.1128/JVI.00218.
    PubMed     Abstract available


  296. SOBEL LEONARD A, Weissman D, Greenbaum B, Ghedin E, et al
    Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus.
    J Virol. 2017 May 3. pii: JVI.00171-17. doi: 10.1128/JVI.00171.
    PubMed     Abstract available


  297. GUEDAN A, Swieboda D, Charles M, Toussaint M, et al
    Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.
    J Virol. 2017;91.
    PubMed     Abstract available


    April 2017
  298. IVINSON K, Deliyannis G, McNabb L, Grollo L, et al
    Salivary blockade protects the lower respiratory tract of mice from lethal influenza.
    J Virol. 2017 Apr 26. pii: JVI.00624-17. doi: 10.1128/JVI.00624.
    PubMed     Abstract available


  299. GILBERTSON B, Ng WC, Crawford S, McKimm-Breschkin JL, et al
    Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza neuraminidase activity.
    J Virol. 2017 Apr 26. pii: JVI.00145-17. doi: 10.1128/JVI.00145.
    PubMed     Abstract available


  300. WATTERS K, Inankur B, Gardiner JC, Warrick J, et al
    Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases.
    J Virol. 2017;91.
    PubMed     Abstract available


  301. TZARUM N, McBride R, Nycholat CM, Paulson JC, et al
    Unique structural features of influenza H15 HA.
    J Virol. 2017 Apr 12. pii: JVI.00046-17. doi: 10.1128/JVI.00046.
    PubMed     Abstract available


  302. SHIN D, Lee J, Park JH, Min JY, et al
    Double PHD Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Interferon-beta Production.
    J Virol. 2017 Apr 12. pii: JVI.02260-16. doi: 10.1128/JVI.02260.
    PubMed     Abstract available


  303. DU Y, Chen M, Yang J, Jia Y, et al
    Molecular Evolution and Emergence of H5N6 Avian Influenza Virus in Central China.
    J Virol. 2017 Apr 12. pii: JVI.00143-17. doi: 10.1128/JVI.00143.
    PubMed     Abstract available


  304. SANTOS JJ, Finch C, Sutton T, Obadan A, et al
    Development of an alternative modified live Influenza B virus vaccine.
    J Virol. 2017 Apr 5. pii: JVI.00056-17. doi: 10.1128/JVI.00056.
    PubMed     Abstract available


  305. ZHAO D, Liang L, Wang S, Nakao T, et al
    Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
    J Virol. 2017;91.
    PubMed     Abstract available


  306. PALMENBERG AC
    Rhinovirus C, Asthma, and Cell Surface Expression of Virus Receptor CDHR3.
    J Virol. 2017;91.
    PubMed     Abstract available


  307. LEWIS-ROGERS N, Seger J, Adler FR
    Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor.
    J Virol. 2017;91.
    PubMed     Abstract available


    March 2017
  308. BOBONE S, Hilsch M, Storm J, Dunsing V, et al
    Phosphatidylserine Lateral Organization Influences the Interaction of Influenza Matrix Protein 1 with Lipid Membranes.
    J Virol. 2017 Mar 29. pii: JVI.00267-17. doi: 10.1128/JVI.00267.
    PubMed     Abstract available


  309. GERLACH T, Hensen L, Matrosovich T, Bergmann J, et al
    pH-optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs.
    J Virol. 2017 Mar 29. pii: JVI.00246-17. doi: 10.1128/JVI.00246.
    PubMed     Abstract available


  310. BENTON DJ, Wharton SA, Martin SR, McCauley JW, et al
    Role of Neuraminidase in Influenza A(H7N9) Receptor Binding.
    J Virol. 2017 Mar 29. pii: JVI.02293-16. doi: 10.1128/JVI.02293.
    PubMed     Abstract available


  311. ERMLER M, Kirkpatrick E, Sun W, Hai R, et al
    Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model.
    J Virol. 2017 Mar 29. pii: JVI.00286-17. doi: 10.1128/JVI.00286.
    PubMed     Abstract available


  312. WANG S, Ren H, Jiang W, Chen H, et al
    Divergent requirement of Fc-FcgammaR interactions for in vivo protection against influenza viruses by two pan-H5 hemagglutinin antibodies.
    J Virol. 2017 Mar 22. pii: JVI.02065-16. doi: 10.1128/JVI.02065.
    PubMed     Abstract available


  313. WHITE MC, Steel J, Lowen AC
    Heterologous packaging signals on HA, but not NA or NS, limit influenza A virus reassortment.
    J Virol. 2017 Mar 22. pii: JVI.00195-17. doi: 10.1128/JVI.00195.
    PubMed     Abstract available


  314. COBBIN JC, Alfelali M, Barasheed O, Taylor J, et al
    Multiple sources of genetic diversity of influenza A viruses during the Hajj.
    J Virol. 2017 Mar 22. pii: JVI.00096-17. doi: 10.1128/JVI.00096.
    PubMed     Abstract available


  315. KWON HI, Kim YI, Park SJ, Song MS, et al
    Evaluation of the immune responses to and cross-protective efficacy of Eurasian H7 avian influenza viruses.
    J Virol. 2017 Mar 22. pii: JVI.02259-16. doi: 10.1128/JVI.02259.
    PubMed     Abstract available


  316. TIAN B, Yang J, Zhao Y, Ivanciuc T, et al
    BRD4 Couples NF-kappaB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
    J Virol. 2017;91.
    PubMed     Abstract available


  317. BOYOGLU-BARNUM S, Todd SO, Meng J, Barnum TR, et al
    Mutating the CX3C motif in the G protein should make a live respiratory syncytial virus vaccine safer and more effective.
    J Virol. 2017 Mar 8. pii: JVI.02059-16. doi: 10.1128/JVI.02059.
    PubMed     Abstract available


  318. LINGEMANN M, Liu X, Surman S, Liang B, et al
    Attenuated Human Parainfluenza Virus type 1 expressing Ebola Virus Glycoprotein GP Administered Intranasally is Immunogenic in African Green Monkeys.
    J Virol. 2017 Mar 1. pii: JVI.02469-16. doi: 10.1128/JVI.02469.
    PubMed     Abstract available


  319. SCHIERHORN KL, Jolmes F, Bespalowa J, Saenger S, et al
    Influenza A virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein facilitating inhibition of PKR.
    J Virol. 2017 Mar 1. pii: JVI.00198-17. doi: 10.1128/JVI.00198.
    PubMed     Abstract available


  320. ZHANG Z, Dong Z, Wei Q, Carr MJ, et al
    A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    J Virol. 2017 Mar 1. pii: JVI.02450-16. doi: 10.1128/JVI.02450.
    PubMed     Abstract available


  321. WIEGAND MA, Gori-Savellini G, Gandolfo C, Papa G, et al
    Respiratory syncytial virus (RSV) vaccine vectored by a stable chimeric and replication-deficient Sendai virus protects mice without inducing enhanced disease.
    J Virol. 2017 Mar 1. pii: JVI.02298-16. doi: 10.1128/JVI.02298.
    PubMed     Abstract available


    February 2017
  322. LESER GP, Lamb RA
    The lateral organization of influenza virus proteins in the budozone region of the plasma membrane.
    J Virol. 2017 Feb 15. pii: JVI.02104-16. doi: 10.1128/JVI.02104.
    PubMed     Abstract available


  323. XU Y, Ramey AM, Bowman AS, DeLiberto TJ, et al
    Low Pathogenic Influenza A Viruses in North American Diving Ducks Contribute to the Emergence of a Novel Highly Pathogenic Influenza A(H7N8) Virus.
    J Virol. 2017 Feb 15. pii: JVI.02208-16. doi: 10.1128/JVI.02208.
    PubMed     Abstract available


  324. DAI M, McBride R, Dortmans JC, Peng W, et al
    Mutation of the 2nd Sialic Acid-Binding Site Resulting in Reduced Neuraminidase Activity Preceded Emergence of H7N9 Influenza A Virus.
    J Virol. 2017 Feb 15. pii: JVI.00049-17. doi: 10.1128/JVI.00049.
    PubMed     Abstract available


  325. JIANG W, Wang S, Chen H, Ren H, et al
    A bivalent heterologous DNA-virus-like particles prime-boost vaccine elicits broad protection against both groups 1 and 2 influenza A viruses.
    J Virol. 2017 Feb 8. pii: JVI.02052-16. doi: 10.1128/JVI.02052.
    PubMed     Abstract available


  326. MATSUMOTO Y, Ohta K, Kolakofsky D, Nishio M, et al
    A point mutation in the RNA-binding domain of human parainfluenza virus type 2 nucleoprotein elicits an abnormally enhanced polymerase activity.
    J Virol. 2017 Feb 8. pii: JVI.02203-16. doi: 10.1128/JVI.02203.
    PubMed     Abstract available


  327. HALL OJ, Nachbagauer R, Vermillion MS, Fink AL, et al
    Progesterone-based contraceptives reduce adaptive immune responses and protection against sequential influenza A virus infections.
    J Virol. 2017 Feb 8. pii: JVI.02160-16. doi: 10.1128/JVI.02160.
    PubMed     Abstract available


  328. PU J, Sun H, Qu Y, Wang C, et al
    M gene reassortment in H9N2 influenza virus promotes early infection and replication: contribution to rising virus prevalence in chickens in China.
    J Virol. 2017 Feb 1. pii: JVI.02055-16. doi: 10.1128/JVI.02055.
    PubMed     Abstract available


  329. YANG W, Punyadarsaniya D, Lambertz RL, Lee DC, et al
    Mutations during the adaptation of H9N2 avian influenza virus to the respiratory epithelium of pigs enhance the sialic acid binding activity and the virulence in mice.
    J Virol. 2017 Feb 1. pii: JVI.02125-16. doi: 10.1128/JVI.02125.
    PubMed     Abstract available


  330. SCHNEIDER-OHRUM K, Cayatte C, Snell Bennett A, Manohar Rajani G, et al
    Immunization with low doses of recombinant post-fusion or pre-fusion RSV F primes for vaccine-enhanced disease in the cotton rat model independent of the presence of a Th1-biasing (GLA-SE) or Th2-biasing (Alum) adjuvant.
    J Virol. 2017 Feb 1. pii: JVI.02180-16. doi: 10.1128/JVI.02180.
    PubMed     Abstract available


    January 2017
  331. NILSSON BE, Te Velthuis AJ, Fodor E
    The role of the PB2 627-domain in influenza A virus polymerase function.
    J Virol. 2017 Jan 25. pii: JVI.02467-16. doi: 10.1128/JVI.02467.
    PubMed     Abstract available


  332. TANG X, Yang Y, Xia X, Zhang C, et al
    Recombinant adenoviruses displaying matrix 2 ectodomain epitopes (M2e) on their fiber proteins as universal influenza vaccines.
    J Virol. 2017 Jan 18. pii: JVI.02462-16. doi: 10.1128/JVI.02462.
    PubMed     Abstract available


  333. VAN DEN HOECKE S, Ehrhardt K, Kolpe A, El Bakkouri K, et al
    Hierarchical and redundant roles of activating FcgammaRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies.
    J Virol. 2017 Jan 11. pii: JVI.02500-16. doi: 10.1128/JVI.02500.
    PubMed     Abstract available


  334. VAN DEN POL AN, Mao G, Chattopadhyay A, Rose JK, et al
    Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    J Virol. 2017 Jan 11. pii: JVI.02154-16. doi: 10.1128/JVI.02154.
    PubMed     Abstract available


  335. KIM SM, Kim YI, Park SJ, Kim EH, et al
    Vaccine efficacy of an inactivated, chimeric HA H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy.
    J Virol. 2017 Jan 11. pii: JVI.01693-16. doi: 10.1128/JVI.01693.
    PubMed     Abstract available


  336. NAITO T, Mori K, Ushirogawa H, Takizawa N, et al
    Generation of a genetically stable high-fidelity influenza vaccine strain.
    J Virol. 2017 Jan 4. pii: JVI.01073-16. doi: 10.1128/JVI.01073.
    PubMed     Abstract available


    December 2016
  337. LI C, Wang Z, Cao Y, Wang L, et al
    Screening for novel small molecule inhibitors targeting the assembling of influenza virus polymerase complex by a BiLC-based reporter system.
    J Virol. 2016 Dec 28. pii: JVI.02282-16. doi: 10.1128/JVI.02282.
    PubMed     Abstract available


  338. YANG L, Zhu W, Li X, Bo H, et al
    Genesis and dissemination of highly pathogenic H5N6 avian influenza viruses.
    J Virol. 2016 Dec 21. pii: JVI.02199-16. doi: 10.1128/JVI.02199.
    PubMed     Abstract available


  339. NOGALES A, Martinez-Sobrido L, Topham DJ, DeDiego ML, et al
    NS1 protein amino acid changes D189N and V194I affect interferon responses, thermosensitivity and virulence of circulating H3N2 human influenza A viruses.
    J Virol. 2016 Dec 21. pii: JVI.01930-16. doi: 10.1128/JVI.01930.
    PubMed     Abstract available


  340. NGUYEN DT, Jang Y, Nguyen TD, Jones J, et al
    Shifting clade distribution, reassortment, and emergence of new subtypes of highly pathogenic avian influenza A(H5) viruses collected in Vietnamese poultry from 2012 to 2015.
    J Virol. 2016 Dec 21. pii: JVI.01708-16. doi: 10.1128/JVI.01708.
    PubMed     Abstract available


  341. NOGALES A, Rodriguez L, Chauche C, Huang K, et al
    A temperature sensitive live-attenuated canine influenza virus H3N8 vaccine.
    J Virol. 2016 Dec 7. pii: JVI.02211.
    PubMed     Abstract available


  342. RAJAO DS, Walia R, Campbell B, Gauger PC, et al
    Reassortment between swine H3N2 and 2009 pandemic H1N1 in the United States resulted in influenza A viruses with diverse genetic constellations with variable virulence in pigs.
    J Virol. 2016 Dec 7. pii: JVI.01763.
    PubMed     Abstract available


    November 2016
  343. ZHANG S, Jiang Y, Cheng Q, Yi Z, et al
    Inclusion body fusion of human parainfluenza virus type 3 regulated by acetylated alpha-tubulin enhances viral replication.
    J Virol. 2016 Nov 23. pii: JVI.01802.
    PubMed     Abstract available


  344. MINAKUCHI M, Sugiyama K, Kato Y, Naito T, et al
    Pre-mRNA processing factor Prp18 is a stimulatory factor of influenza virus RNA synthesis and possesses the NP chaperone activity.
    J Virol. 2016 Nov 16. pii: JVI.01398.
    PubMed     Abstract available


  345. ZANIN M, Kocer ZA, Poulson RL, Gabbard JD, et al
    The Potential for Low Pathogenic Avian H7 Influenza A Viruses to Replicate and Cause Disease in a Mammalian Model.
    J Virol. 2016 Nov 16. pii: JVI.01934.
    PubMed     Abstract available


  346. MARVIN SA, Russier M, Huerta CT, Russell CJ, et al
    Influenza overcomes cellular blocks to productively replicate impacting macrophage function.
    J Virol. 2016 Nov 2. pii: JVI.01417.
    PubMed     Abstract available


  347. CROSBY CM, Matchett WE, Anguiano-Zarate SS, Parks CA, et al
    Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses.
    J Virol. 2016 Nov 2. pii: JVI.00720.
    PubMed     Abstract available


  348. TANG Q, Wang X, Gao G
    ZAPS inhibits influenza A viral protein expression and is antagonized by the virus encoded NS1.
    J Virol. 2016 Nov 2. pii: JVI.01909.
    PubMed     Abstract available


  349. IWATSUKI-HORIMOTO K, Nakajima N, Shibata M, Takahashi K, et al
    Microminipigs as an animal model for influenza A virus infection.
    J Virol. 2016 Nov 2. pii: JVI.01716.
    PubMed     Abstract available


  350. WANG X, Ilyushina NA, Lugovtsev VY, Bovin NV, et al
    Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    J Virol. 2016 Nov 2. pii: JVI.01512.
    PubMed     Abstract available


    October 2016
  351. WANG J, Li J, Zhao L, Cao M, et al
    The dual roles of the HA segment-specific noncoding nucleotides in the extended duplex region of the influenza A virus RNA promoter.
    J Virol. 2016 Oct 26. pii: JVI.01931.
    PubMed     Abstract available


  352. TENG O, Chen ST, Hsu TL, Sia SF, et al
    CLEC5A-mediated enhancement of the inflammatory response in myeloid cells contributes to influenza pathogenicity in vivo.
    J Virol. 2016 Oct 19. pii: JVI.01813.
    PubMed     Abstract available


  353. ZHU P, Liang L, Shao X, Luo W, et al
    Host cellular protein TRAPPC6ADelta interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking.
    J Virol. 2016 Oct 19. pii: JVI.01757.
    PubMed     Abstract available


  354. TAKEMAE N, Harada M, Nguyen PT, Nguyen T, et al
    Vietnamese influenza A viruses of swine between 2010 and 2015: multiple introductions of A(H1N1)pdm09 viruses into the pig population and diversifying genetic constellations of enzootic IAV-S.
    J Virol. 2016 Oct 19. pii: JVI.01490.
    PubMed     Abstract available


  355. SOBEL LEONARD A, McClain MT, Smith GJ, Wentworth D, et al
    Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.
    J Virol. 2016 Oct 5. pii: JVI.01657.
    PubMed     Abstract available


  356. SUN X, Zeng H, Kumar A, Belser JA, et al
    Constitutively expressed IFITM3 protein in human pulmonary endothelial cells poses an early infection block to human influenza viruses.
    J Virol. 2016 Oct 5. pii: JVI.01254.
    PubMed     Abstract available


  357. RABBANI MA, Ribaudo M, Guo JT, Barik S, et al
    Identification of IFN-stimulated gene (ISG) proteins that inhibit human parainfluenza virus type 3.
    J Virol. 2016 Oct 5. pii: JVI.01551.
    PubMed     Abstract available


    September 2016
  358. NELSON MI, Stucker KM, Schobel SA, Trovao NS, et al
    Introduction, evolution, and dissemination of influenza A viruses in exhibition swine, USA, 2009-2013.
    J Virol. 2016 Sep 28. pii: JVI.01457.
    PubMed     Abstract available


  359. SUN X, Belser JA, Pulit-Penaloza JA, Zeng H, et al
    Pathogenesis and transmission assessments of two H7N8 influenza A viruses recently isolated from turkey farms in Indiana using mouse and ferret models.
    J Virol. 2016 Sep 28. pii: JVI.01646.
    PubMed     Abstract available


  360. KIRUI J, Mondal A, Mehle A
    Ubiquitination up-regulates influenza virus polymerase function.
    J Virol. 2016 Sep 28. pii: JVI.01829.
    PubMed     Abstract available


  361. WU Y, Gao F, Qi J, Bi Y, et al
    Resistance to mutant group-2 influenza neuraminidases of an oseltamivir-zanamivir hybrid inhibitor.
    J Virol. 2016 Sep 21. pii: JVI.01703.
    PubMed     Abstract available


  362. NURNBERGER C, Zimmermann V, Gerhardt M, Staeheli P, et al
    Influenza virus susceptibility of wild-derived CAST/EiJ mice results from two amino acid changes in the MX1 restriction factor.
    J Virol. 2016 Sep 21. pii: JVI.01213.
    PubMed     Abstract available


  363. MARJUKI H, Mishin VP, Chai N, Tan MW, et al
    Human monoclonal antibody 81.39a effectively neutralizes emerging influenza A viruses of group 1 and 2 hemagglutinins.
    J Virol. 2016 Sep 14. pii: JVI.01284.
    PubMed     Abstract available


    June 2016
  364. ROSTAD CA, Stobart CC, Gilbert BE, Pickles RJ, et al
    A recombinant respiratory syncytial virus vaccine candidate attenuated by a low-fusion F protein is immunogenic and protective against challenge in cotton rats.
    J Virol. 2016 Jun 8. pii: JVI.00012.
    PubMed     Abstract available


  365. PALOMO C, Mas V, Thom M, Vazquez M, et al
    Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    J Virol. 2016;90:5485-98.
    PubMed     Abstract available


    May 2016
  366. SHARMA A, Wu W, Sung B, Huang J, et al
    Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    J Virol. 2016;90:5068-74.
    PubMed     Abstract available


  367. OTIENO JR, Agoti CN, Gitahi CW, Bett A, et al
    Molecular Evolutionary Dynamics of Respiratory Syncytial Virus Group A in Recurrent Epidemics in Coastal Kenya.
    J Virol. 2016;90:4990-5002.
    PubMed     Abstract available


  368. ALJABR W, Touzelet O, Pollakis G, Wu W, et al
    Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach.
    J Virol. 2016;90:4876-88.
    PubMed     Abstract available


    January 2016
  369. GONZALEZ-SANZ R, Mata M, Bermejo-Martin J, Alvarez A, et al
    ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    J Virol. 2016;90:3428-38.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: